These are the stocks posting the largest moves before the bell Monday.Market Insiderread more
The major indexes have stretched to all-time highs and are riding one of their best first halves in decades.Trading Nationread more
The brokerage says that the globe is "one step away" from recession as the world's two largest economies head to the G-20 summit.Marketsread more
As candidates from Elizabeth Warren and Bernie Sanders to John Delaney jockey for position in the 2020 Democratic primary, business issues will come up in the first debates.2020 Electionsread more
A bipartisan team of senators introduced the DASHBOARD Act Monday, which would make social media companies disclose the value of user data.Technologyread more
Trump says he would impose additional sanctions against Iran in a bid to prevent the country obtaining nuclear weapons.World Politicsread more
The prospect of another military conflict in the Middle East prompted international benchmark Brent crude to climb around 5% last week.Energyread more
Here are the biggest calls on Wall Street on MondayInvestingread more
Tensions between the U.S. and Iran will likely escalate in the near future, a former adviser to the Iranian government said on Monday.Energyread more
Millennial stocks are looking fly this month, and one name could be on the verge of exploding in the next year.Trading Nationread more
Chinese vice commerce minister said Monday that Beijing would like the U.S. to cancel "inappropriate" actions against Chinese companies.China Economyread more
It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed:
Allergan: "OK, I mean, it's a very torturous situation. They've got a particular drug that might come off patent. There's a challenge. They put the rights to it to an Indian tribe, and what can I say? It forestalls what I regard as double jeopardy in the process. More importantly, I think the stock's very inexpensive and it should be bought."
USG Corporation: "It spiked in advance [of Hurricane Irma], now it's coming down. Now, my take is very clear here: let 'em come down and then buy 'em. I think it's absolutely the right thing because of mold, and you've got to replace it because of mold."
Arena Pharmaceuticals: "They reinvented themselves in a way that makes it so the stock went from being overvalued to being undervalued because it came up in the new formulation. I think it's a good one."